Advice
Following a full submission
betaine anhydrous (Cystadane®) is not recommended for use within NHS Scotland as adjunctive treatment of homocystinuria in line with the manufacturer’s licence.
The manufacturer did not provide sufficient clinical data to demonstrate efficacy.
Download detailed advice51KB (PDF)
Medicine details
- Medicine name:
- betaine anhydrous oral powder (Cystadane)
- SMC ID:
- 407/07
- Indication:
- as adjunctive treatment of homocystinuria along with other therapies such as vitamin B6 (pyridoxine), vitamin B12 (cobalamin), folate and a methionine restricted diet
- Pharmaceutical company
- Orphan Europe (UK) Ltd
- BNF chapter
- Nutrition and blood
- Submission type
- Full
- Status
- Not recommended
- Date advice published
- 08 October 2007